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Introduction {#sec1}
============

DNA replication is a highly regulated process, and its fidelity plays a primary role in maintaining genome stability ([@bib1]). DNA synthesis can be divided into the stages of pre-replication complex (pre-RC) formation, replication initiation, elongation, and termination. Licensing of replication origins begins with chromatin binding of the origin recognition complex (ORC) and Cdc6/Cdc18. These factors facilitate the Cdt1-dependent loading of the mini-chromosome maintenance (MCM) complex, and subsequently multiple additional replication factors associate with the replication origin following activation of cyclin-dependent kinase (CDK) and Dbf4-dependent kinase (DDK). Pol ε is recruited to origins as part of the initiation complex and effects leading strand synthesis following helicase activation and priming by Pol α, whereas Pol δ is thought to replicate the lagging strand ([@bib35], [@bib53], [@bib57]).

Efficient and accurate DNA replication elongation requires a balanced supply of deoxyribonucleoside triphosphates (dNTPs), generated in eukaryotes through the reduction of ribonucleoside diphosphates (NDPs) to deoxyribonucleoside diphosphates (dNDPs), which is catalyzed by ribonucleotide reductase (RNR). RNR is a heterotetrameric or possibly higher-order complex ([@bib41]) that in the fission yeast *Schizosaccharomyces pombe* is minimally formed from two catalytic Cdc22 subunits and two small Suc22 regulatory subunits.

RNR activity is highly regulated through a number of mechanisms ([@bib24]). In *S. pombe*, RNR is transcriptionally regulated by the *Mlu*I cell-cycle box (MCB) binding factor (MBF) complex ([@bib40]). The MBF complex consists of essential core subunits including the product of the *START* gene *cdc10*^*+*^, together with Res1 and Res2, which constitute a heterodimeric DNA binding domain, and the co-activators Rep1 and Rep2 ([@bib4], [@bib10], [@bib44], [@bib47], [@bib56], [@bib58], [@bib65]). The MBF complex, which is functionally analogous to the E2F complex in humans induces transcription of a set of genes, including *cdc22*^+^ (encoding the catalytic RNR subunit) *cdt1*^+^ and *cdc18*^+^ (encoding the replication licensing factors), at the G1/S transition of the cell cycle to facilitate DNA synthesis. In addition, RNR is subject to MBF-dependent transcriptional regulation by DNA integrity checkpoints in response to DNA damage and replication stresses. Following replication stress caused by RNR inhibition by hydroxyurea (HU), MBF-dependent transcription of the *cdc22*^+^ gene is activated by the S-phase checkpoint kinase Cds1 through phosphorylation of Cdc10 ([@bib18]) and by inhibition of the MBF-associated transcriptional co-repressors Nrm1 and Yox1, thus facilitating resumption of DNA replication ([@bib8], [@bib16], [@bib17], [@bib23]). Activation of the DNA damage checkpoint displays a more complex regulation of Cdc10-dependent transcription. Although DNA damage in G2 cells significantly upregulates a number of *Mlu*I-box transcripts, such as *cdc22*^+^, in a Rad3 and Chk1-dependent manner ([@bib60]), it is clear that Chk1 activation can also inhibit MBF-dependent transcription of certain genes and phosphorylation of Cdc10 can result in its release from MBF targets ([@bib28]). RNR activity is also post-translationally regulated through direct inhibition by Spd1 both during the cell cycle and following stress conditions ([@bib25], [@bib39], [@bib45]). Moreover, RNR is also under allosteric control by dNTPs and NTPs. A mutation in the R1 subunit of RNR *cdc22-D57N* alleviates allosteric feedback inhibition by dATP and causes elevated dNTP pools ([@bib11], [@bib14], [@bib21]).

DNA replication origin usage can be positively or negatively regulated by the chromatin environment ([@bib3], [@bib33], [@bib43], [@bib63]). Previous studies have described links between Set2-dependent histone H3 lysine 36 (H3K36) methylation and the timing of DNA replication ([@bib7], [@bib52]), although the mechanism is unclear. Furthermore, loss of the tumor suppressor SETD2, in human cells, is associated with slower replication fork progression and with DNA replication stress ([@bib30], [@bib51], [@bib55]). Moreover, studies in both fission yeast and humans showed histone H3K36 methylation to be cell-cycle regulated, with H3K36me3 levels peaking at the G1-S transition ([@bib36], [@bib50]). Together, these findings led us to study the function of histone H3K36 methylation in DNA replication.

Here, we establish a role for Set2 in efficient DNA replication and in facilitating efficient dNTP synthesis through promoting MBF gene transcription under normal conditions and in response to genotoxic stress.

Results {#sec2}
=======

*set2*Δ Cells Show Perturbed Progression through S Phase {#sec2.1}
--------------------------------------------------------

We wanted to investigate a possible role for Set2 in DNA replication. Both wild-type and *set2*Δ cells were grown to log phase in YES medium and processed for flow cytometry analysis. Asynchronous *set2*Δ cells do not exhibit significant S-phase delay compared to wild-type cells ([Figure S1](#mmc1){ref-type="supplementary-material"}A). This result was determined by flow cytometry analysis, which may not be sufficiently sensitive to detect subtle effects on the length of S phase. We therefore performed nucleotide incorporation experiments in wild-type and *set2*Δ cells in asynchronous cultures. Efficient incorporation of 5-ethynyl-2′-deoxyuridine (EdU) into fission yeast requires expression of both thymidine kinase (TK) and a nucleoside transporter (hENT1) ([@bib27]). Here, we showed that wild-type cells, or *set2*Δ cells expressing *Drosophila melanogaster* deoxyribonucleoside kinase (DmdNK) under the control of the fission yeast a*dh* promoter, together with the human equilibrative nucleoside transporter (hENT1) (*adh-Dm-dNK-adh-hENT1*) ([@bib22]) are sensitive to 5 μM EdU, whereas wild-type or *set2*Δ cells are not sensitive to EdU ([Figure 1](#fig1){ref-type="fig"}A), consistent with previous studies showing that EdU is toxic to incorporating strains ([@bib27]). With medium containing 100 μM EdU for 15 min, no significant cell-cycle delay was observed in wild-type or *set2*Δ cells expressing *adh-Dm-dNK-adh-hENT1* ([Figure 1](#fig1){ref-type="fig"}B). However, during a short pulse, significantly more cells incorporating EdU were detected using fluorescent microscopy in the absence of Set2 ([Figures 1](#fig1){ref-type="fig"}C and 1D), suggesting a prolonged S phase in *set2*Δ cells.Figure 1Set2 Is Required for Efficient DNA Replication(A) Effects of EdU incorporation on viability. Serial dilutions (10-fold) of wild-type, *set2*Δ, *tk hENT* (*ura4::adh-dmNK-NAT-adh-hENT1 ura4-aim*), and *tk hENT set2*Δ (*ura4::adh-dmNK-NAT-adh-hENT1 ura4-aim set2*Δ) cells were spotted on to YE3S plates containing EdU at the indicated concentration.(B) Effects of EdU incorporation on cell-cycle progression. Cells were grown in EMM containing 100 μM EdU for 15 min, and then processed and analyzed by flow cytometry.(C) Cells from (B) were fixed in 70% ethanol and conjugated to Alexa Fluor 488 azide before being imaged by fluorescence microscopy.(D) Quantification of Edu-positive cells in wild-type compared to *set2*Δ cells.(E) Wild-type, *set2*Δ or *set2-R255G* cells were arrested in G1 by nitrogen starvation and released, and samples were taken at time points indicated and subjected to FACS analysis. The red dashed line box indicates the delayed S-phase progression in *set2*Δ or *set2-R255G* compared to wild-type cells.(F) *cdc25-22* and *cdc25-22 set2*Δ cells arrested in G2 at 35.5°C for 4.25 hr followed by a shift back to the permissive temperature of 25°C. Aliquots of cells were taken every 20 min and fixed in 70% ethanol for FACS and septation index analysis (see also [Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). The red dashed line box indicates the delayed S-phase progression in *cdc25-22 set2*Δ (S phase starts at 80 min after G2/M block and release) compared to *cdc25-22* cells (S phase starts at 100 min after G2/M block and release).

To explore this further, we investigated a role for Set2 in DNA replication using a synchronous G1 block and release experiment. Both wild-type and *set2*Δ cells were synchronized in G1 by nitrogen starvation and released from the block at 32°C. Samples were then taken at the indicated time points and analyzed by flow cytometry. In wild-type (WT) cells, DNA replication started 2 hr after release from the G1 arrest and was finished by 5 hr ([Figure 1](#fig1){ref-type="fig"}E, WT). In contrast, we found that *set2*Δ cells displayed a significant delay in S-phase progression ([Figure 1](#fig1){ref-type="fig"}E, *set2*Δ), as was also observed in a methyltransferase-dead *set2-R255G* mutant cells ([Figure 1](#fig1){ref-type="fig"}E, *set2-R255G*). This indicates that methyltransferase activity of Set2 is required for efficient DNA replication. Similar conclusions were drawn from results obtained from cells synchronized using a *cdc25-22* G2-M block and release protocol ([Figure 1](#fig1){ref-type="fig"}F; [Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). Collectively, these findings identify a role for Set2 in efficient DNA replication initiation and or elongation in synchronous cells.

*set2*Δ Does Not Alter the Efficiency of Replication Origins {#sec2.2}
------------------------------------------------------------

Given that histone modifications have been reported to affect the activity of origin firing, we examined the possible role of Set2 in regulating the pattern of replication origin usage. We performed a polymerase usage sequence (Pu-seq) method to map genome-wide origin usage as previously described ([@bib15], [@bib31]). In wild-type cells, we identified 1,386 initiation sites at 18°C and 1,207 at 34°C including efficient (\>50% usage per cell cycle), moderately efficient (50%--25%), and inefficient (\>25%) origins ([Figure 2](#fig2){ref-type="fig"}A, wild-type). In the *set2*Δ background, we mapped 1,444 initiation sites at 18°C and 1,303 at 34°C ([Figure 2](#fig2){ref-type="fig"}A, *set2*Δ), suggesting a modest increase in the number of replicating origins in *set2*Δ compared to wild-type cells. Interestingly, this increase is mostly caused by increased use of inefficient origins ([Figure 2](#fig2){ref-type="fig"}B) and the overall efficiency of the majority of origins was not changed ([Figure 2](#fig2){ref-type="fig"}C)---for example, the average efficiency of the top 10% of efficient origins ([Figure S2](#mmc1){ref-type="supplementary-material"}). Analysis of the distribution of origin usage in *set2*Δ cells revealed that these new inefficient origins are randomly located throughout the yeast genome. However, there is no significant difference of the number of origins identified at sub-telomeric regions of *set2*Δ compared to wild-type cells ([Figure S2](#mmc1){ref-type="supplementary-material"}). In conclusion, we found that *set2*Δ subtly alters genome-wide replication origin usage but does not significantly alter the efficiency of the vast majority of origins. The main effect is to increase the total number of inefficient (previously dormant) origins used in the fission yeast genome, suggestive of a general slowdown in replication after origins have fired ([@bib2]).Figure 2Set2 Suppresses Inefficient Origin Firing(A) The genome-wide plot of origin usage in vegetative *set2*Δ cells (red) in comparison with wild-type (blue) cells at 18°C or 34°C. Origin efficiencies were calculated from Pu-seq data.(B) The quantification of origin efficiencies in asynchronous wild-type and *set2*Δ cells at 18°C or 34°C.(C) Analysis of the 500 most efficient origins in wild-type and *set2*Δ cells at 18°C or 34°C. The x axis is the ranked 500 origins; the y axis is the efficiency from the Pu-seq data.

MBF-Regulated Gene Expression Is Downregulated in *set2*Δ Cells {#sec2.3}
---------------------------------------------------------------

We have previously investigated gene expression levels in response to DNA damage in a *set2*Δ background ([@bib50]). We found a number of genes to be upregulated and downregulated in response to DNA damage compared to wild-type in a *set2*Δ background. Notably, a cluster of four transcripts: *cdc18*^*+*^, *cdt1*^*+*^, *cdc22*^*+*^, and *tos4*^*+*^, involved in cell-cycle regulation, were consistently downregulated in *set2*Δ cells following treatment with bleomycin for 30 min when compared to wild-type ([Figure 3](#fig3){ref-type="fig"}A). The products of two of these genes, Cdt1 and Cdc18, are required for Mcm2-7 association with ORC in pre-RC formation ([@bib48]). The third, Cdc22, is the large subunit of RNR whose interaction with Suc22 (the small subunit) is required for dNTP production ([@bib20]). The fourth, Tos4, is a putative G1-S transcription factor containing a forkhead domain, and is an effector of the DNA replication checkpoint ([@bib5], [@bib26]).Figure 3A Cluster of G1-S Genes Are Downregulated following DNA Damage in the Absence of Set2(A) Left panel: Heatmap depicting *cdc18*^*+*^, *cdt1*^*+*^, *cdc22*^*+*^, and *tos4*^*+*^ transcript levels in wild-type and *set2*Δ cells following 30 min of treatment with 5 μg/mL bleomycin. Blue depicts downregulated compared to before damage, and red depicts upregulated compared to before damage. Right panel: Quantification of *cdc18*^*+*^, *cdt1*^*+*^, *cdc22*^*+*^, and *tos4*^*+*^ transcript levels in wild-type (blue) and *set2*Δ (red) cells following 30 min of treatment with 5 μg/mL bleomycin. Data represent mean of two experiments with independently derived RNA.(B) Quantification of *cdc18*^*+*^, *cdt1*^*+*^, *cdc22*^*+*^, *nrm1*^*+*^, and *tos4*^*+*^ transcript levels in wild-type and *set2*Δ cells following 30 min of treatment with 5 μg/mL bleomycin. Error bars represent SD from three biological replicates. The asterisk (^∗^) represents significant difference compared with wild-type and *set2*Δ (p \< 0.05, t test).(C) The protein levels of Cdc18 were examined in wild-type and *set2*Δ cells following 5 μg/mL bleomycin treatment. Samples of cells were taken at the indicated time points, and cell extracts were made using TCA method. Cdc18 was detected using an antibody against the TAP tag. α-Tubulin is shown as a loading control.(D) The protein levels of Cdc22 were examined in in wild-type and *set2*Δ cells following 5 μg/mL bleomycin addition. Total cell extracts were prepared at the indicated times and analyzed by western blotting. Cdc22 was detected using an anti-GFP antibody. α-Tubulin is shown as a loading control.(E) The protein levels of Cdt1 were examined in wild-type and *set2*Δ cells following 5 μg/mL bleomycin addition. Samples of cells were taken at the indicated time points, and cell extracts were made using TCA method. Cdt1 was detected using an antibody against the TAP tag.

Analysis of the promoters of these genes indicated that they are all cell-cycle regulated and under the transcriptional control of the MBF complex, strongly suggesting that Set2 has a function in MBF transcription activation. Accordingly, following qPCR validation of the above results, we found *set2*Δ-dependent downregulation of *cdc18*^*+*^, *cdt1*^*+*^, *cdc22*^*+*^, and *tos4*^*+*^, both in the absence and presence of bleomycin, suggesting a role for Set2 in facilitating basal, as well as damage-induced MBF transcription ([Figure 3](#fig3){ref-type="fig"}B). Furthermore, we found one other MBF-dependent gene that also showed reduced transcription in *set2Δ* cells compared to wild-type following bleomycin treatment: *nrm1*^*+*^ ([Figure 3](#fig3){ref-type="fig"}B). However, other MBF-dependent genes such as *ctp1*^*+*^ and *mrc1*^*+*^ showed no alteration in transcription based on microarray analysis (data not shown). In accordance with a role for Set2 in MBF activation following DNA damage, we found that protein levels of Cdc18, Cdc22, and Cdt1 were downregulated in response to bleomycin treatment in a *set2*Δ background compared to wild-type cells ([Figures 3](#fig3){ref-type="fig"}C--3E).

Licensing Factors Cdt1 and Cdc18 Are Misregulated in *set2*Δ Cells {#sec2.4}
------------------------------------------------------------------

Given the replication delay seen in *set2*Δ cells and the involvement of three members of the cluster in efficient DNA replication, we analyzed mRNA and protein levels of these replication factors, Cdc18, Cdt1, and Cdc22, in the absence of genotoxic stress. In asynchronous cell cultures where most cells are in G2, we found that these replication factors were all downregulated in a *set2*Δ background compared to a wild-type ([Figures 4](#fig4){ref-type="fig"}A and 4B), further supporting a role for Set2 in DNA replication. Next, we investigated protein levels of the licensing factors Cdc18 and Cdt1 using a synchronous G1 block and release experiment. Both licensing factors showed oscillating protein levels in wild-type cells ([Figures 4](#fig4){ref-type="fig"}D and 4F, wild-type), in accordance with normal S-phase progression ([Figures 4](#fig4){ref-type="fig"}C and 4E). In contrast, *set2*Δ cells showed delayed expression of Cdc18 and Cdt1 after release from G1 arrest ([Figures 4](#fig4){ref-type="fig"}C--4F, *set2*Δ), and the final levels achieved were lower than seen in wild-type cells. Similar conclusions were drawn from results obtained from cells synchronized using a *cdc25-22* G2-M block and release protocol ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). In accordance with protein levels, *set2*Δ cells also showed delayed mRNA expression of *cdc18*^*+*^ and *cdt1*^*+*^ after release from G1 arrest ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B), supporting the idea that changes are transcriptional, although there may also be post-translational changes. This result suggests that a delay in pre-RC formation or origin binding of initiating factors is contributing to the slow S phase observed for *set2*Δ cells ([Figure 1](#fig1){ref-type="fig"}). Consistent with this, previous studies in budding yeast showed that chromatin association of initiation factor Cdc45 was delayed in a *set2*Δ strain ([@bib52]), presumably due to delayed expression of licensing factors.Figure 4Replication Factors Are Misregulated in *set2*Δ Cells(A) Transcript levels of *cdc18*^*+*^, *cdc22*^*+*^, and *cdt1*^*+*^ were established in exponentially growing wild-type and *set2*Δ cells. RNA was extracted with Qiagen RNeasy kit and relative transcript levels of *cdc18*^*+*^, *cdc22*^*+*^, and *cdt1*^*+*^ were established by RT-qPCR. Error bars represent SD of three biological repeats. The asterisk (^∗^) represents significant difference compared with wild-type and *set2*Δ.(B) Cdc18, Cdt1, or Cdc22 protein levels of exponentially growing wild-type and *set2*Δ cells. Cell extracts were prepared from vegetative cells and processed for western blot. Immunoblots of total cell lysates were probed with PAP or GFP antibody. α-Tubulin is shown as a loading control.(C) *cdc18-TAP* or *cdc18-TAP set2*Δ cells were arrested in G1 by nitrogen starvation and released, and samples were taken at time points indicated and subjected to FACS analysis.(D) In parallel, *cdc18-TAP* and *cdc18-TAP set2*Δ cells were processed for western blotting at indicated times.(E) *cdt1-TAP* or *cdt1-TAP set2*Δ cells were arrested in G1 by nitrogen starvation, released, and samples taken at time points indicated and subjected to FACS analysis.(F) In parallel, *cdt1-TAP* and *cdt1-TAP set2*Δ cells were processed for western blotting at indicated times.(G) A similar experiment to that described in (C) was carried out using *cdc22-CFP* or *cdc22-CFP set2*Δ cells.(H) A similar experiment to that described in (D) was carried out using *cdc22-CFP* or *cdc22-CFP set2*Δ cells. Immunoblots of total cell extracts were probed with GFP antibody. α-Tubulin is shown as a loading control.

To see whether the delayed S-phase entry in *set2*Δ cells could be rescued by increasing the expression of Cdt1 and Cdc18, the genes were ectopically expressed from a *REP81X* plasmid in *cdc25-22* and *cdc25-22 set2*Δ cells. However, in a *cdc25-22 set2*Δ background, cells grown in the absence of thiamine had a similar profile to those grown in its presence, indicating overexpression of Cdc18 and Cdt1 did not suppress the replication defect observed in *set2*Δ cells ([Figure S5](#mmc1){ref-type="supplementary-material"}). This suggests that other DNA replication steps were affected and account for the slow growth phenotype.

Of the cluster of four genes that have significantly decreased transcript levels in response to bleomycin in *set2*Δ cells, Tos4 has been identified in *S. cerevisiae* as a G1-S transcription factor ([@bib26]). Given the replication delay seen in *set2*Δ cells and the involvement of the other three members of the cluster in efficient DNA replication, the cell-cycle progression of *tos4*Δ cells was analyzed. However, in contrast to the defective S-phase progression seen in *set2*Δ cells, a *cdc25-22 tos4*Δ double mutant did not exhibit significant delay in cell-cycle progression following G2-M block and release ([Figure S6](#mmc1){ref-type="supplementary-material"}).

Set2 Is Required for Balanced dNTP Synthesis {#sec2.5}
--------------------------------------------

The four dNTP precursors for DNA synthesis are potentially limiting for initiation and elongation if levels are too low ([@bib62]). Importantly, imbalanced dNTP pools caused by altered expression and/or activity of RNR can affect cell-cycle progression and lead to mutagenesis ([@bib13], [@bib21]). Because our earlier results showed that Cdc22 levels were also downregulated in a *set2*Δ mutant ([Figure 4](#fig4){ref-type="fig"}B), we monitored the levels of the catalytic subunit of RNR, Cdc22, in wild-type and *set2*Δ cells during a G1 block and release cell cycle. In contrast to wild-type, RNR protein and mRNA levels did not rise around the time of S phase, consistent with the slow S-phase progression seen in *set2*Δ cells ([Figures 4](#fig4){ref-type="fig"}G and 4H; [Figure S4](#mmc1){ref-type="supplementary-material"}C). This result indicates that the replication defect in a *set2*Δ background could have arisen from low or imbalanced levels of dNTPs, which could possibly cause replication progression defects in a *set2*Δ background. To verify this, we measured dNTP levels in asynchronous *set2*Δ cells and found that dNTP levels were lower, with dCTP, dGTP, and dATP levels being significantly reduced (p \< 0.05) compared to that of wild-type ([Figure 5](#fig5){ref-type="fig"}A), suggesting imbalanced dNTP levels could be limiting for DNA replication.Figure 5Elevated dNTP Pools Speed Up S-Phase Progression in *set2*Δ Cells(A) dNTP levels were measured in exponential growth wild-type, *spd1*Δ, *set2*Δ, and *set2*Δ *spd1*Δ strains. Means ± SEs of three experiments are shown. The asterisk (^∗^) represents significant difference compared with wild-type and *set2*Δ and *set2*Δ and *set2*Δ*spd1*Δ strains.(B) Removal of RNR inhibitor Spd1 suppresses prolong S-phase progression in *set2*Δ cells. Flow cytometry analysis of the indicated strains after release from G1 arrest into EMM+N at 32°C.(C) The S-phase failure of *set2*Δ cells was poorly suppressed by the *cdc22-D57N* mutation. Flow cytometry analysis of the indicated strains after release from G1 arrest into EMM+N at 32°C.

Elevated dNTP Pools Suppress Slow Replication in *set2*Δ Cells {#sec2.6}
--------------------------------------------------------------

To confirm whether the cause of replication delay in *set2*Δ cells was through Set2-dependent dNTP synthesis during the cell cycle, we tested whether it was possible to suppress the replication defects of *set2*Δ cells by increasing dNTP pools. To achieve this, the gene encoding Spd1, an inhibitor of RNR ([@bib39], [@bib61]), was deleted in a *set2*Δ background. We found that Spd1 depletion restored dNTP levels in *set2*Δ cells ([Figure 5](#fig5){ref-type="fig"}A). We repeated the G1 block and release experiment and found that deletion of *spd1*^*+*^ considerably rescued the DNA replication delay in *set2*Δ cells ([Figure 5](#fig5){ref-type="fig"}B), consistent with a Set2 function in promoting dNTP synthesis. However, we do not exclude the possibility that Spd1 may have other functions in regulating S-phase progression in fission yeast ([@bib22]). In contrast, the S-phase failure of *set2*Δ cells was poorly suppressed by the *cdc22-D57N* mutation ([Figure 5](#fig5){ref-type="fig"}C), although the result is difficult to interpret as the single *cdc22-D57N* mutant releases poorly from the G1 block, possibly due to abnormal dNTP levels ([@bib13], [@bib49]).

S-Phase Delay in *set2*Δ Cells Is Checkpoint Dependent {#sec2.7}
------------------------------------------------------

We wanted to test whether delayed S-phase progression resulting from loss of H3K36 methylation resulted directly by limiting S-phase progression through nucleotide depletion or was exacerbated by checkpoint activation resulting from dNTP depletion. Indeed, it is well established that inhibition of DNA replication due to depletion or imbalanced of dNTP pools leads to activation of the S-phase checkpoint ([@bib19], [@bib34], [@bib46]). To test this idea, we deleted *rad3*^*+*^ encoding the checkpoint sensor Rad3 (ATR) in *set2*Δ cells and monitored cell-cycle progression by fluorescent-activated cell sorting (FACS) analysis. We found that deleting *rad3*^*+*^ suppressed the prolonged S-phase progression in *set2*Δ cells ([Figure 6](#fig6){ref-type="fig"}A). Consistent with this result, deleting *cds1*^*+*^ encoding the Cds1 replication checkpoint kinase also suppressed the slow S-phase progression in *set2*Δ cells ([Figure 6](#fig6){ref-type="fig"}B). This finding suggests that imbalanced nucleotide pools activate the intra-S checkpoint resulting in S-phase delay. Alternatively, DNA synthesis from low levels of pyrimidines (dCTP or dTTP) could cause DNA damage that activates the S-phase checkpoint, therefore arresting the cell-cycle progression ([@bib34]).Figure 6The *set2*Δ Mutation Causes a Rad3 (ATR)-Dependent S-Phase Progression Defect(A) Deletion of Rad3 (ATR) increases the speed of S-phase progression in *set2*Δ cells. Flow cytometry analysis of wild-type (WT), *set2*Δ and *set2*Δ *rad3*Δ strains after release from G1 into EMM+N at 32°C.(B) Deletion of Cds1 (Chk2) increases the speed of S-phase progression in *set2*Δ cells. Flow cytometry analysis of wild-type (WT), *set2*Δ and *set2*Δ *cds1*Δ strains after release from G1 into EMM+N at 32°C.(C) Serial dilution of a wild-type and *cds1*Δ, *set2*Δ, and *H3K36R* mutants were spotted onto YES medium containing 10 mM HU. Plates were incubated at 30°C for 2--3 days.(D) Each fixed culture from wild-type, *set2*Δ *chk1*Δ, *cds1*Δ, or *rad3*Δ strain was stained with 4′-6-diamidino-2-phenylindole (DAPI) and analyzed by fluorescence microscopy showing nuclear morphology for each strain.(E) *set2*Δ *chk1*Δ cells were grown in YES medium containing 10 mM HU at indicated times and stained with DAPI followed by microscopy analysis for nuclear morphology.

DNA Integrity Checkpoint Activation Is Proficient in *set2*Δ Cells {#sec2.8}
------------------------------------------------------------------

The above result implies that DNA replication checkpoint signaling is not affected by inactivation of Set2. To confirm this, we analyzed the function of Set2 in checkpoint signaling in response to replication stress. In contrast to deleting the checkpoint genes, *set2*Δ or *H3K36R* mutants exhibited only modest HU sensitivity ([Figure 6](#fig6){ref-type="fig"}C; [Figure S7](#mmc1){ref-type="supplementary-material"}A). Treatment with HU was not found to result in an increased "cut" phenotype, in which incompletely replicated DNA is divided into two daughter cells, in a *set2*Δ background ([Figure 6](#fig6){ref-type="fig"}D), suggesting that mitosis was arrested in the presence of incomplete DNA replication and that the intra-S-phase checkpoint in *set2*Δ cells was intact. In fission yeast, Cds1 is the effector kinase of the DNA synthesis checkpoint pathway, stabilizing stalled forks and triggering transcriptional activation of G1-S-specific genes ([@bib18]). Moreover, Cds1 and Chk1 establish the redundant pathways of HU-induced checkpoint arrest and double mutants exhibit mitotic catastrophe in response to DNA damage ([@bib38], [@bib64]). We therefore further investigated the role of Set2 in HU-induced checkpoint arrest through examining the effect of inactivating Set2 in *chk1*Δ cells. We observed that, like wild-type cells, *set2*Δ *chk1*Δ cells exhibited an elongated phenotype in the presence of HU, confirming that Set2 is not required for proficient Cds1 activation ([Figure 6](#fig6){ref-type="fig"}E). Consistent with this result, HU-induced activation of Cds1 was not affected by the loss of Set2 ([Figure S7](#mmc1){ref-type="supplementary-material"}B) as previously reported in fission yeast ([@bib32]). We did not detect Cds1 phosphorylation in unperturbed *set2*Δ cells, perhaps due to low checkpoint activation reflecting a cell-cycle delay rather than an arrest. Taken together, these results suggest that Set2 is proficient in replication checkpoint activation.

Roles have recently been described for the budding yeast Set2 and the human homolog, SETD2, in DNA damage signaling ([@bib12], [@bib29]). To investigate whether Set2 acts in the DNA damage checkpoint response, the DNA damage-induced mobility shift of Chk1 on SDS-PAGE was examined. The modified form of Chk1 was detected in bleocin-treated wild-type and *set2*Δ cells, indicating that Chk1 activation is not affected by loss of Set2 ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Furthermore, we found that DNA damage-dependent Crb2 phosphorylation is still observed in the absence of Set2 ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Consistent with this result, *set2*Δ cells exhibited an elongated phenotype in the presence of bleocin in comparison with *chk1*Δ cells ([Figure S7](#mmc1){ref-type="supplementary-material"}D). Taken together, these results suggested that *set2*Δ cells are proficient for the G2-M arrest in the presence of DNA damage in *S. pombe*.

Set2 Facilitates Efficient DNA Replication through Promoting MBF-Induced dNTP Synthesis {#sec2.9}
---------------------------------------------------------------------------------------

Our results suggest that Set2 is required for induced expression of a subset of MBF-dependent genes in response to bleomycin treatment. Previous studies have shown that MBF-dependent transcription is induced in response to replication stress ([@bib6]), but can be both induced and inhibited in response to DNA damage ([@bib28], [@bib60]). Therefore, Set2 could either have a role in the induction of MBF-dependent transcription in response to replication stress or the prevention of DNA damage-induced inhibition of MBF target gene expression. To test this, we first performed RT-qPCR analysis of MBF-dependent genes following HU treatment to assess the role of Set2 in replication stress-induced transcription. Cells were treated with HU for an extended period of time to establish whether Set2 is required for the induction and/or maintenance of MBF-dependent gene expression in response to replication stress. We found that Set2 is required for rapid induction and sustained expression of MBF-dependent *cdc22*^+^ or *cdc18*^+^ under HU-induced replication stress conditions ([Figures 7](#fig7){ref-type="fig"}A and 7B).Figure 7Set2 Facilitates Efficient Binding of MBF Components in Response to Genotoxic Stress(A) Set2 has a direct function in regulating MBF activity in response to replication stress. Left panel: quantification of *cdc22*^*+*^ transcript levels in wild-type, *chk1*Δ, *set2*Δ, and *set2*Δ *chk1*Δ cells following 5-hr treatment with 10 mM HU. Data represent mean of three experiments with independently derived RNA. Right panel: quantification of *cdc18*^*+*^ transcript levels in wild-type, *chk1*Δ, *set2*Δ, and *set2*Δ *chk1*Δ cells following 5-hr treatment with 10 mM HU. Data represent mean of three experiments with independently derived RNA.(B) dNTP levels were measured in exponential growth wild-type, *yox1*Δ, *set2*Δ, and *set2*Δ *yox1*Δ strains. Means ± SEs of three experiments are shown. The asterisk (^∗^) represents significant difference compared with WT and *set2Δ*, WT and *yox1Δ*, *set2*Δ and *set2*Δ*yox1*Δ.(C) Removal of MBF inhibitor Yox1 speeds up S-phase progression in *set2*Δ cells. Flow cytometry analysis of the indicated strains after release from G1 arrest into EMM+N at 32°C.(D) Levels of Res1-Myc binding at *cdc18*^*+*^, *cdc22*^*+*^, *cdt1*^*+*^, and *byr3*^*+*^ (negative control) promoters were shown in the presence or absence of DNA damage. Cells of logarithmically growing cultures (YES medium) of *set2*Δ, *res1-Myc*, *set2*Δ *res1-Myc* strains were collected for ChIP before and 30 min after treatment with 5 μg/mL bleomycin. Data represent the mean of three experiments with independently derived RNA and error bars (±SE) are shown. The asterisk (^∗^) represents significant difference compared with wild-type (p \< 0.05, t test).(E) Set2-dependent di-methylation of H3K36 at promoters is induced upon genotoxic stress. Levels of H3K36me3 at *cdc18*^*+*^, *cdc22*^*+*^, *cdt1*^*+*^, *byr3*^*+*^ (negative control), and *rps17*^*+*^ (negative control) promoters were presented in wild-type or *set2*Δ strains without and with DNA damage treatment. Cells of logarithmically growing wild-type and *set2*Δ cultures were collected for ChIP before and 30 min after treatment with 5 μg/mL bleomycin. Data represent the mean of three experiments with independently derived RNA and error bars (±SE) are shown. The asterisk (^∗^) represents significant difference compared with wild-type (p \< 0.05, t test).(F) Set2-dependent tri-methylation of H3K36 at promoters is induced upon genotoxic stress. Levels of H3K36me3 at *cdc18*^*+*^, *cdc22*^*+*^, *cdt1*^*+*^, *byr3*^*+*^ (negative control), and *rps17*^*+*^ (negative control) promoters were presented in wild-type or *set2*Δ strains without and with DNA damage treatment. Cells of logarithmically growing wild-type and *set2*Δ cultures were collected for ChIP before and 30 min after treatment with 5 μg/mL bleomycin. Data represent the mean of three experiments with independently derived RNA and error bars (±SE) are shown. The asterisk (^∗^) represents significant difference compared with wild-type (p \< 0.05, t test).

To examine the possibility that Set2 depletion causes a higher degree of replication stress-induced DNA damage, which in turn indirectly activates Chk1 in response to replication stress and inactivates MBF at *cdc22*^*+*^ and *cdc18*^*+*^ promoters, we analyzed these MBF targets in *set2*Δ *chk1*Δ compared to *set2*Δ cells. The *set2*Δ and *set2*Δ *chk1*Δ cells show a similar pattern of MBF-dependent expression ([Figure 7](#fig7){ref-type="fig"}A), indicating the decrease in MBF-dependent transcription in HU is likely to be a direct effect of *set2*^*+*^ deletion, rather than DNA damage-dependent inhibition. This result supports the idea that the loss of G1-S transcription in a *set2*Δ background was due to MBF complex dysfunction. In support of our findings, deletion of *yox1*^+^, encoding the MBF transcription repressor Yox1, significantly elevated dNTP pools in *set2*Δ cells ([Figure 7](#fig7){ref-type="fig"}B), and further suppressed the prolonged-S phase in *set2*Δ cells, presumably due to elevated RNR levels ([Figure 7](#fig7){ref-type="fig"}C). These results together support a role for Set2-dependent H3K36 methylation in facilitating efficient DNA synthesis through regulation of MBF-dependent gene expression, primarily through regulation of RNR transcript levels.

To further investigate a role for Set2 in promoting MBF-dependent transcriptional regulation, chromatin immunoprecipitation (ChIP) analysis of MBF binding was assessed in wild-type and *set2*Δ cells. We found that binding of the MBF transcription factor subunit Res1 at *cdc22*^*+*^ and *cdt1*^*+*^ promoters is significantly reduced in a *set2*Δ background compared to wild-type in the presence of bleomycin ([Figure 7](#fig7){ref-type="fig"}D). Furthermore, we investigated whether Set2 was recruited to these gene promoters in a wild-type background following genotoxic stress. ChIP analysis indicated that the promoter regions of these MBF-dependent genes underwent H3K36 di- and tri-methylation ([Figures 7](#fig7){ref-type="fig"}E and 7F), demonstrating that Set2-dependent H3K36 methylation has the potential to regulate the binding of MBF. Together, these results suggest a role for Set2 in facilitating recruitment of the MBF transcription factor to MCB-containing promoters to facilitate their expression in response to genotoxic stress.

Discussion {#sec3}
==========

We have established important roles for Set2-dependent H3K36 methylation in facilitating efficient DNA replication, together with promoting the transcriptional responses to both replication and genotoxic stresses. Our data support a role for H3K36 methylation in facilitating these functions through promoting the basal and genotoxic stress-induced transcription of a subset of MBF-regulated genes.

We find Set2 facilitates efficient DNA replication through maintaining dNTP pools. Accordingly, the S-phase delay observed in a *set2*Δ background can be suppressed by increasing dNTP levels either through deleting the MBF repressor gene *yox1*^*+*^, or by deletion of *spd1*^*+*^ encoding an inhibitor of RNR in a *set2*Δ background. These data support an important role for Set2 in facilitating efficient DNA replication through MBF-dependent dNTP synthesis. Although replication origins fire with largely equivalent efficiency in wild-type and *set2*Δ cells, we observed that a number of additional low-efficiency origins (dormant origins) are utilized in *set2*Δ cells compared to wild-type cells. We found the S-phase delay in a *set2*Δ background could be largely suppressed by deleting Rad3 (ATR) or Cds1 (CHK2), strongly suggesting that the S-phase delay arose through activation of the intra-S checkpoint in a *set2*Δ background. These data are consistent with an insufficient supply of dNTPs in a *set2*Δ background leading to increased replication stress and or DNA damage, and to subsequent checkpoint-dependent S-phase delay.

Analysis of DNA replication origins in a *set2*Δ background revealed an increase in the number of inefficient origins being fired, which are randomly distributed throughout the yeast genome as would be expected when replication is slowed (see above). Interestingly, a role for Set2 has recently been described in facilitating the recruitment of Shugoshin (Sgo2) to sub-telomeric regions and for the formation of highly condensed chromatin bodies or "knobs" flanking telomeric heterochromatin ([@bib42]). Sgo2 regulates replication timing at the sub-telomeres by limiting Sld3 loading, and sub-telomeric regions were found to replicate early in *sgo2*Δ cells ([@bib59]). Therefore, loss of Set2 could regulate early firing of sub-telomeric origins through facilitating increased Sld3 loading.

Our findings support a role for Set2 in facilitating the transcription of a subset of MBF-regulated genes, both at the basal level (without damage) and when activated in response to genotoxic stress. Consistent with this, Set2 loss resulted in significantly reduced mRNA and protein expression of a subset of MBF genes including *cdc18*^*+*^, *cdt1*^*+*^, and *cdc22*^*+*^ in asynchronous or synchronized conditions or in response to HU or bleomycin. How might Set2 facilitate MBF-dependent transcription? Our data are consistent with a role for Set2-dependent H3K36 methylation in promoting MBF-dependent transcription through regulating the binding and or activity of the MBF complex to the promoters of MBF target genes. In this respect, we find significantly reduced levels of Res1 at MBF promoters in a *set2*Δ background following DNA damage. We note that genes whose expression is particularly sensitive to loss of Set2 exhibit a promoter pattern associated with two MCB elements (5′-AACGCG-3′ and 5′-CGCGNCGCG-3′), which is present only in a subset of MBF-regulated transcripts. Therefore, Set2 loss may affect expression of genes whose promoters contain similar MCB arrangements more robustly. However, the precise mechanism as to how H3K36 methylation promotes MBF binding to target genes in the absence or presence of genotoxic stress is currently unclear and will require further investigation. We previously showed that H3K36 modification was cell-cycle regulated with H3K36 tri-methylation being associated with an increased 1C DNA content ([@bib50]). Such timing would be consistent with a role in facilitating MBF-dependent transcription, described here.

The findings presented here strongly support a highly conserved role for H3K36 methylation in facilitating efficient DNA replication from yeast to mammalian cells in response to replication stress ([@bib30], [@bib51]). As loss of SETD2 is observed in a number of human cancer types ([@bib37]), delineating the role of H3K36 methylation in cellular stress responses in both yeast and human cells will be of particular biological and clinical interest.

Experimental Procedures {#sec4}
=======================

Yeast Strains, Media, and Genetic Methods {#sec4.1}
-----------------------------------------

The strains used in this study are listed in [Table S1](#mmc1){ref-type="supplementary-material"}. Standard media and growth conditions were used throughout this work. Cultures were grown in rich media (YE6S) or Edinburgh minimal media (EMM) at 32°C with shaking, unless otherwise stated. Nitrogen starvation was carried out using EMM lacking NH~4~Cl.

Serial Dilution Assay {#sec4.2}
---------------------

A dilution series for the indicated mutant cells was spotted onto YES plates. Plates were incubated at 25°C, 32°C, or 36°C for 2--3 days before analysis.

Cell-Cycle Analysis {#sec4.3}
-------------------

Cells were synchronized in G1 by nitrogen starvation. Log-phase cells were released into minimal medium lacking nitrogen for 16 hr. During the time course of nitrogen re-feeding, samples of cells were taken for methanol/acetone fixation, followed by microscopy and FACS analysis. Cells were synchronized in G2-M by Cdc25 inactivation. *cdc25-22* cells were grown at 25°C, shifted to 35.5°C for 4.25 hr, and then released, and samples were taken for FACS analysis at indicated time points.

Microarray Analysis {#sec4.4}
-------------------

Microarray analysis was performed as previously described ([@bib50], [@bib54]). In brief, Alexa 555- or 647-labeled cDNA was produced from the RNA, using a Superscript direct cDNA labeling system (Invitrogen) and Alexa 555 and 647 dUTP label mix. The cDNA was then purified using an Invitrogen PureLink PCR Purification system. The cDNA was hybridized to the array using a Gene Expression Hybridization kit (Agilent). The array was an Agilent custom-designed array containing 60-mer oligonucleotides synthesized in situ on the array and contained 4 × 44,000 probes. Following hybridization for at least 17 hr, the array was washed using a Gene Expression Wash Buffer kit (Agilent) and scanned in an Agilent Array Scanner. The microarray signal was extracted using GenePix.

Microscopy Analysis {#sec4.5}
-------------------

Asynchronous cell culture was treated with 10 mM HU at indicated temperature before being fixed in methanol. Samples were rehydrated and stained with 4′,6-diamidino-2-phenylindole (DAPI) before examination using Zeiss Axioplan 2ie microscope, Hamamatsu Orca ER camera, and micromanager software. For visualization of Rad22-GFP foci, cells were incubated at 25°C or 35°C for 5 hr before being fixed and visualized as above.

Pu-Seq {#sec4.6}
------

Pu-seq technique was performed as previously described ([@bib15]). Briefly, DNA was extracted from cells grown to log phase either at 18°C or 34°C as indicated. For "wild-type" datasets, two strains were used, both strains containing *rnh201* deletion together with either polymerase δ (*cdc6-L591G*) or polymerase ε (*cdc20-M630F*) mutations. These strains incorporate more rNTPs on the strands synthetized by the mutant polymerase. These sites can be mapped by Pu-seq. For the *set2*Δ datasets, the strain also contained these mutations along with *rnh201* and *cdc6-L591G* or *cdc20-M630F*. The isolated DNA was then subjected to alkali treatment (0.3 M NaOH, 2 hr at 55°C), which digested the DNA at the positions of rNTP incorporation and also separated the double-stranded DNA. The resulting ssDNA fragments were size selected on agarose gel (fragments between 300 and 500 bp were isolated). These fragments were then used for creating strand-specific next-generation sequencing libraries and sequenced on a Next-seq Illumina platform resulting in ∼10M reads from each strain. Reads were aligned to the *Schizosaccharomyces pombe* reference sequence (<http://www.pombase.org/downloads/genome-datasets>), the reads were mapped using bowtie2 and the data were analyzed and origin positions and efficiencies were determined using the tools published and described in detail in [@bib15] and [@bib31] with default variables except that the "percentile threshold for origins" option was set to 0.2 = 20th percentile. Efficient origins were determined as origins with higher than 50% efficiency and inefficient origins had less than 25% efficiency. Because our previous work has indicated subtle changes to origin firing at different temperatures, we performed the analysis on cultures grown at either 18°C or 34°C.

ChIP {#sec4.7}
----

Yeast culture was grown in YES to OD~595~ = 0.3--0.5. 45 mL of culture was incubated with 1% of formaldehyde for 20 min for cross-linking. The reaction was quenched with 125 mM glycine. Cells were lysed with lysis buffer (50 mM HEPEs-KOH, pH 7.5, 140 mM sodium chloride, 1% Triton X-100, 0.1% sodium deoxycholate, 1 mM EDTA) supplemented with protease inhibitors (cOmplete Tablets Mini, EASYpack; Roche) by vortexing with glass beads (0.5 mm; Biospec Products). Chromatin was sheared to 500--1,000 bp by sonication (amplitude, 100%; process time, 5 min; ON time, 30 s; OFF time, 2 min). Chromatin lysate was incubated with specific antibodies (anti-H3K36me2 Active Motif 39255; antiH3K36me3 Active Motif 61101; Myc-tag Santa Cruz 9E10: sc-40) at 4°C overnight rotating. Chromatin was pulled down with cold 50% protein A-Sepharose beads in lysis buffer (Sigma; P3391) for 3 hr and washed six times with washing buffer (50 mM Tris-HCl, 1% Triton X-100, 150 mM sodium chloride, 5 mM EDTA, 0.5% NP-40). De-cross-linking was performed with 10% Chelex in ultra-pure water and boiling for 10 min. DNA enrichment was established by qPCR with SYBR green according to the manufacturer's recommendations and percentage of the whole-cell extract method. Primers used in this study are listed in [Table S2](#mmc1){ref-type="supplementary-material"}.

Protein Analysis {#sec4.8}
----------------

Protein extracts were made by trichloroacetic acid (TCA) extraction and analyzed by western blotting as described previously ([@bib50]). TAP-tagged proteins were detected with peroxidase-antiperoxidase-soluble complex (P1291; Sigma). Cdc22-GFP was detected using antibody 1181446000 (Roche), and α-tubulin was detected with antibody T5168 (Sigma). Phos-tag Acrylamide gel was used to detect Cds1-P (Wako).

HPLC Analysis of dNTP {#sec4.9}
---------------------

dNTP analysis was carried out as previously described ([@bib45]).

qPCR Analysis {#sec4.10}
-------------

qPCR analysis was carried out as previously described ([@bib9]). Total RNA was prepared using the RNeasy Plus Kit (Qiagen) as indicated in the manufacturer's manual. Transcript levels were determined by RT-qPCR using the iScript One-Step RT-PCR kit with SYBR Green Supermix (Bio-Rad). RT-PCRs were run on a Chromo-4 Real-Time PCR Detector (Bio-Rad) and obtained experimental values analyzed using MJ Opticon Analysis Software 3.0. Furthermore, data were normalized against actin and investigated using the C(t) method. Primers used in this study are listed in [Table S2](#mmc1){ref-type="supplementary-material"}.
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